About Transcription factor AP-2-alpha
Transcription factor AP-2-alpha (TFAP2A) is a protein
from Homo sapiens identified by UniProt accession
P05549, 437 residues long.
MolForge cross-references it against 0 known binders and
502 disease associations.
Target properties
| Protein name | Transcription factor AP-2-alpha |
| UniProt accession | P05549 |
| Gene | TFAP2A |
| Organism | Homo sapiens |
| Length | 437 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (502)
Diseases linked to this target (Open Targets).
- branchiooculofacial syndrome · score 0.80
- Branchio-oculo-facial syndrome · score 0.70
- genetic disorder · score 0.52
- neurodegenerative disease · score 0.49
- cleft lip · score 0.37
- microphthalmia · score 0.34
- epicanthal fold · score 0.34
- High palate · score 0.34
- Hypertelorism · score 0.34
- Epicanthus · score 0.34
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P05549-F1 | alphafold | PREDICTED | 67.93 | — |
Amino-acid sequence (437 residues)
MLWKLTDNIK YEDCEDRHDG TSNGTARLPQ LGTVGQSPYT SAPPLSHTPN ADFQPPYFPP PYQPIYPQSQ DPYSHVNDPY SLNPLHAQPQ PQHPGWPGQR QSQESGLLHT HRGLPHQLSG LDPRRDYRRH EDLLHGPHAL SSGLGDLSIH SLPHAIEEVP HVEDPGINIP DQTVIKKGPV SLSKSNSNAV SAIPINKDNL FGGVVNPNEV FCSVPGRLSL LSSTSKYKVT VAEVQRRLSP PECLNASLLG GVLRRAKSKN GGRSLREKLD KIGLNLPAGR RKAANVTLLT SLVEGEAVHL ARDFGYVCET EFPAKAVAEF LNRQHSDPNE QVTRKNMLLA TKQICKEFTD LLAQDRSPLG NSRPNPILEP GIQSCLTHFN LISHGFGSPA VCAAVTALQN YLTEALKAMD KMYLSNNPNS HTDNNAKSSD KEEKHRK
Explore Transcription factor AP-2-alpha with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets